Gauteng has largest ARV programme in country
Nolundi Mfecane, the province’s project manager for the comprehensive HIV/AIDS plan, says the province has ‘exceeded its target of 10 000 people on treatment by the end of the financial year in March’.
At present, 25 facilities are offering treatment at least four days a week and this will be increased to 45 by March 2006 with a target of 25 000 patients.
Mfecane said healthworkers were ‘very committed to the programme’.
‘People prefer to work for the ARV programme because they are learning a lot and because they can see the huge impact it is making on patients,’ said Mfecane.
Non-governmental organisations are assisting with community education, and were also providing lay counsellors who are able to visit patients at their homes. Four community radio stations publicise the programme every day, providing potential patients with valuable information about where they can get treatment.
Those who need food support are given free supplies of Philani, fortified porridge.
Lack of staff and space are the biggest problems for the programme, said Mfecane. In addition, some facilities were charging patients ‘and this is a barrier that could cause a problem for adherence so we are addressing this’.
The National Health Laboratory Service has been able to provide results for CD4 tests in two to three days, while viral load results take five days. CD4 tests (measure of immunity in the blood) are crucial as people need to have a CD4 count of less than 200 to qualify for the drugs.
Between last April and December, the NHLS has processed 96 566 CD4 tests and 10 808 viral load tests.
‘So far, there have been no serious adverse drug reactions and no deaths,’ says Mcefance. ‘But some of the reported side effects of the drugs include dizziness, rash, peripheral neuropathy (pain or numbness in hands and feet), tiredness, abdominal pain and diarrhoea.’ ‘ Health-e News Service.
Author
-
Kerry Cullinan is the Managing Editor at Health-e News Service. Follow her on Twitter @kerrycullinan11
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Gauteng has largest ARV programme in country
by Kerry Cullinan, Health-e News
June 6, 2005